What are the recommended treatments for syphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Syphilis Testing and Treatment

Diagnostic Testing

Syphilis diagnosis relies on serologic testing combined with clinical presentation consistent with active or latent infection. 1

  • Nontreponemal tests (RPR or VDRL) should be used for initial screening and monitoring treatment response 2
  • Treponemal tests confirm the diagnosis but correlate poorly with disease activity and should not be used to assess treatment response 2
  • Do not switch between different nontreponemal test methods (e.g., RPR and VDRL) when monitoring serologic response, as results cannot be directly compared 2
  • CSF examination is indicated for patients with neurological signs/symptoms, tertiary syphilis, ophthalmic disease, or those whose serologic titers fail to decline appropriately 2, 3
  • HIV testing should be performed in all patients diagnosed with syphilis 4
  • Dark field microscopy can confirm primary syphilis when mucocutaneous lesions are present 5

Treatment by Stage

Primary and Secondary Syphilis

Benzathine penicillin G 2.4 million units IM as a single dose is the definitive treatment for primary and secondary syphilis. 2, 3, 6

  • This regimen has four decades of proven efficacy in achieving local cure, preventing sexual transmission, and preventing late sequelae 4
  • For children: Benzathine penicillin G 50,000 units/kg IM (up to adult dose of 2.4 million units) as a single dose 4, 3
  • Children should have CSF examination to exclude neurosyphilis and evaluation by child-protection services 4

Early Latent Syphilis

Benzathine penicillin G 2.4 million units IM as a single dose 2, 3

  • Early latent syphilis is defined as infection acquired within the preceding year based on documented seroconversion, fourfold increase in titer, history of symptoms, or having a sex partner with documented early syphilis 2

Late Latent Syphilis and Tertiary Syphilis

Benzathine penicillin G 7.2 million units total, administered as 3 doses of 2.4 million units IM at weekly intervals 2, 3, 6

  • If a dose is missed, an interval of 10-14 days between doses may be acceptable before restarting the sequence 2
  • Late latent syphilis is defined as infection of more than one year duration or unknown duration 6

Neurosyphilis

Aqueous crystalline penicillin G 18-24 million units daily, administered as 3-4 million units IV every 4 hours for 10-14 days 6

  • High-dose IV penicillin G (above 10 million units) should be administered slowly due to potential electrolyte imbalance from potassium content 7, 8
  • Penicillin G contains approximately 1.68 mEq potassium per million units 7

Alternative Treatments for Penicillin-Allergic Patients

Non-Pregnant Adults

For primary and secondary syphilis: Doxycycline 100 mg orally twice daily for 14 days 2, 3, 6

For late latent syphilis: Doxycycline 100 mg orally twice daily for 28 days 2, 3

  • Tetracycline 500 mg orally four times daily is an alternative, though compliance is better with doxycycline due to less frequent dosing 6
  • Ceftriaxone 1 g daily (IM or IV) for 8-10 days may be considered, though optimal dosing is not well established 6
  • Azithromycin should not be used due to widespread macrolide resistance in T. pallidum in the United States 6

Pregnant Women and Neurosyphilis

Penicillin is the only proven effective therapy for preventing maternal transmission and treating neurosyphilis. 2, 3, 6

  • Pregnant women with penicillin allergy must undergo desensitization and be treated with penicillin 2, 3, 6
  • Alternative regimens are not adequately studied in pregnancy 6

Special Populations

HIV-Infected Patients

HIV-infected patients should receive the same penicillin regimens as non-HIV-infected patients 2, 3, 6

  • HIV-infected patients may have atypical serologic responses but generally respond well to standard treatment 2
  • More frequent monitoring is recommended: every 3 months rather than every 6 months 6
  • Recent evidence suggests that single-dose BPG plus 7-day doxycycline achieves higher serologic response rates (79.5% vs 70.3%) compared to BPG alone in PWH 9

Pregnant Women

All pregnant patients should be screened for syphilis three times: at the first prenatal visit, during the third trimester, and at delivery 1

  • Parenteral penicillin G is the only therapy with documented efficacy for preventing maternal transmission 2, 3
  • Up to 40% of fetuses with in-utero exposure to syphilis are stillborn or die from infection during infancy 1

Follow-Up and Monitoring

Quantitative nontreponemal serologic tests should be repeated at 3,6,12, and 24 months after treatment 2, 3

  • Expected serologic response: A fourfold decline in titer within 6 months for primary/secondary syphilis and within 12-24 months for late syphilis 2, 3
  • Treatment failure is defined as: Failure of nontreponemal test titers to decline fourfold within 6 months after therapy for primary or secondary syphilis 2, 3
  • If treatment failure is suspected, patients should be re-evaluated for HIV infection and undergo CSF examination 2
  • Serologic tests may decline more slowly in patients who have had previous syphilis infections 6

Management of Sexual Partners

Persons exposed within 90 days preceding diagnosis of primary, secondary, or early latent syphilis should be treated presumptively, even if seronegative 4, 2, 3

  • Persons exposed >90 days before diagnosis should be treated presumptively if serologic test results are not immediately available and follow-up is uncertain 4, 2
  • Patients with syphilis of unknown duration and high nontreponemal titers (≥1:32) may be considered infected with early syphilis for partner notification purposes 4
  • Long-term sex partners of patients with late syphilis should be evaluated clinically and serologically 4, 3

Time periods for identifying at-risk sex partners:

  • Primary syphilis: 3 months plus duration of symptoms 4
  • Secondary syphilis: 6 months plus duration of symptoms 4
  • Early latent syphilis: 1 year 4

Important Clinical Considerations

Jarisch-Herxheimer Reaction

An acute febrile reaction may occur within 24 hours after any syphilis therapy, especially in early syphilis 2, 6

  • Symptoms include fever, headache, myalgia, and other constitutional symptoms 2, 6
  • Patients should be informed about this possible adverse reaction before treatment 2

Critical Pitfalls to Avoid

  • Do not use oral penicillin preparations for syphilis treatment as they are ineffective 2
  • Do not rely solely on treponemal test antibody titers to assess treatment response 2
  • Avoid bacteriostatic antibiotics (chloramphenicol, erythromycins, sulfonamides, tetracyclines) concurrently with penicillin, as they may antagonize the bactericidal effect 7, 8
  • Do not perform routine lumbar puncture for primary or secondary syphilis unless clinical signs or symptoms of neurologic or ophthalmic involvement are present 4
  • Be aware that false-positive glucose reactions may occur with Benedict's solution, Fehling's solution, or Clinitest tablets after penicillin G treatment 7, 8

Prevention Strategies

Routine screening of sexually active people aged 15-44 years at least once, and at least annually for those at increased risk 1

  • Men who have sex with men (MSM) comprised 32.7% of all males with primary and secondary syphilis in 2023 1
  • Doxycycline postexposure prophylaxis: 200 mg doxycycline taken within 72 hours after sex is recommended for MSM and transgender women with a history of sexually transmitted infection in the past year 1
  • Counseling about condom use should be provided 1

References

Research

Syphilis: A Review.

JAMA, 2025

Guideline

Syphilis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Syphilis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment for Acute Syphilis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.